Date:4/29/2009

the calculation of net income per share: Weighted average common shares outstanding - basic 21,912 21,674 21,826 21,499 Weighted average common shares outstanding - diluted 22,302 22,393 22,324 22,261 ABAXIS, INC. Condensed Consolidated Balance Sheets (Unaudited and in thousands) March 31, March 31, 2009 2008 Current assets: Cash and cash equivalents $49,237 $17,219 Short-term investments 20,776 6,991 Trade receivables, net 21,983 20,873 Inventories, net 15,735 18,657 Prepaid expenses 957 427 Net deferred tax asset - current 4,676 2,426 Total current assets 113,364 66,593 Long-term investments 4,886 35,463 Property and equipment, net 14,798 14,599 Intangible assets, net 5,175 375 Other assets 24 5 Net deferred tax asset - non-current 2,464 3,868 Total assets $140,711 $120,903 Current liabilities: Accounts payable $3,963 $6,421 Accrued payroll and related expenses 3,698 4,277 Other accrued liabilities 1,150 1,369 Deferred revenue 1,024 807 Warranty reserve 1,714 1,219 Total current liabilities 11,549 14,093 N
'/>"/>

SOURCE Abaxis, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine news :

1. Abaxis to Report Fourth Quarter Fiscal 2009 Financial Results Wednesday, April 29, 2009
2. ABAXIS Realigns North American Medical Sales and Marketing
3. Abaxis, Inc. to Attend Lazard Capital Markets Medical Technologies Conference
4. Abaxis, Inc. to Present at Sidoti & Companys Thirteenth Annual New York Emerging Growth Institutional Investor Forum
5. Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009
6. ABAXIS Announces Launch of Two New Products at the NAVC
7. ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.
8. Abaxis, Inc. to Present at Sidoti & Companys Sixth Annual Palm Beach Emerging Growth Institutional Investor Forum
9. Abaxis, Inc. to Present at Needham & Companys Eleventh Annual Growth Stock Conference
10. Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status
11. Abaxis, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference